Document is current
Any future updates will be listed below
-
Authors
Ghirardello, Mattia
Yruela, Inmaculada
Merino, Pedro https://orcid.org/0000-0002-2202-3460
Sackstein, Robert https://orcid.org/0000-0003-1757-891X
Sanz-Martínez, Ignacio https://orcid.org/0000-0002-0639-8561
Hurtado-Guerrero, Ramón https://orcid.org/0000-0002-3122-9401
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (NCI U01 CA225730)
- License Information
-
More Information
Article History
Received: 7 July 2025
Accepted: 14 November 2025
First Online: 8 December 2025
Competing interests
: Robert Sackstein has ownership of intellectual property related to “Glycosyltransferase-Programmed Stereosubstitution” (GPS), a technology to effectuate cell surface glycan engineering/glycocalyx editing. The remaining authors declare no competing interests.
